- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00411463
Psychotherapy for Bipolar II Depression, Pilot Study, Phase II
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh /University of Pittsburgh Medical Center (UPMC)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Meets DSM-IV Criteria for Bipolar Disorder, Type II, currently depressed;
- HRSD-25 ≥15
- Age 18-65 years;
- Able to give informed consent;
- Women of child bearing potential will be included if they agree to use adequate contraception for the duration of the study.
Exclusion Criteria:
- Not competent to give informed consent in the opinion of the investigator (e.g., psychotic at time of evaluation);
- Unwilling or unable to comply with study requirements;
- Meets DSM-IV criteria for borderline personality disorder or antisocial personality disorder;
- Active substance abuse within the past 6 months(episodic abuse related to mood episodes will not exclude a subject);
- Currently a high suicide risk, as assessed by an active plan and intent to behave in a way that risks ending ones life;
- Non-English speaking;
- Significant, unstable, medical illness that might confound symptom scores or preclude treatment with pharmacotherapy
- Currently applying for disability because of psychiatric illness (we have found that these individuals have a vested interested in appearing to remain ill which potentially confounds outcome scores).
- Women who are pregnant, lactating or plan to become pregnant during their study participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Psychotherapy
Subjects randomized to the Psychotherapy arm will receive Interpersonal and Social Rhythm Therapy (IPSRT-BPII)
|
IPSRT is comprised of three components: psychoeducation, social rhythm therapy, and standard IPT as developed for unipolar depression. Psychoeducation focuses on a) the illness and its consequences, b) treatment options and associated side effects, and c) prodromal symptoms/detection of early warning symptoms.
Other Names:
|
Experimental: Medication
Subjects randomized to the medication arm will receive the FDA approved medication Seroquel (quetiapine)
|
Subjects will be started at 100 mg/day titrated to a maximum of 800 mg /day Day 1-BID doses totaling 100 mg/day, increased to 400 mg/day on Day 4 in increments of up to 100 mg/day in BID divided doses, by Day 6 begin titration up to a maximum dose of 800 mg/day in increments no greater than 200 mg/day. This titration schedule may be adjusted based on the subject's response and ability to tolerate Seroquel. Subjects who are unable to tolerate the study medications, or for whom the study medications are an inappropriate clinical choice, will be treated openly by a clinic physician according to the standard of care guidelines designated by the American Psychiatric Association (2002) for the treatment of bipolar disorder.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Greater Than or Equal to 50% Reduction in Depression Scores, With a Mania Score Less Than or Equal to 10
Time Frame: Week 12
|
Overall response rates (defined as greater than or equal to 50% reduction in depression scores without an increase in mania scores) were 29% (n=4) in the IPSRT group and 27% (n=3) in the quetiapine group.
HRSD-25 scores are based on first 17 responses.
Eight items are scored on a 5-pt scale, from 0 (not present) to 4 (severe.)
Other nine items on the assessment are scored from 0-2.
The higher the score on the HRSD-25, the worse the outcome is considered to be.
A score of 0-7 is considered to be normal; 8-13 indicates mild depression, 14-18 indicates moderate depression, 19-22 indicates severe depression, and any score greater than or equal to 23 indicates very severe depression.
The YMRS is an 11 point assessment.
There are 4 items assessed on a scale ranging from 0 to 8 and the other 7 items are graded on a 0 to 4 scale.
As with the HRSD, the higher the score on the YMRS indicates the presence of more or more severe manic symptoms and is associated with a worse outcome.
|
Week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Life (QOL) Collected Using the Q-LES-Q (Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form)
Time Frame: Baseline and Week 12
|
The total score is derived by summing item scores 1 to 14. Higher scores are indicative of greater enjoyment or satisfaction in each domain.
The Q-LES-Q-SF % maximum total score is calculated as 100% × (Q-LES-Q-SF total score - 14) / 56, and can range from 0% to 100%.
|
Baseline and Week 12
|
Descriptive Measures of the Feasibility of IPSRT-BPII
Time Frame: Week 12
|
Feasibility was assessed by ability to enroll, randomize, and retain participants in this trial.
Completion of the study was used as evidence of feasibility.
|
Week 12
|
Number of Participants With a Response
Time Frame: Week 12
|
Number of participants with response defined as an average of 50% (or greater) reduction in the subject's baseline HRSD-25 score over three consecutive weeks and a current YMRS score ≤ 10
|
Week 12
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Holly Swartz, M.D., University of Pittsburgh
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0608080
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar II Disorder
-
University of ChicagoCompleted
-
Medical University of South CarolinaMilken InstituteCompletedBipolar Disorder | Bipolar I Disorder | Bipolar II DisorderUnited States
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
-
Joshua RosenblatRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderCanada
-
National Cheng-Kung University HospitalUnknownBipolar Disorder IITaiwan
-
Örebro County CouncilSchool of Law, Psychology and Social Work, Örebro UniversityCompletedBipolar Disorder, Type IISweden
-
University Hospital, GrenobleActive, not recruitingBipolar Disorder | Bipolar I Disorder | Bipolar II DisorderFrance
-
Ege UniversityActive, not recruitingBipolar Disorder | Bipolar I Disorder | Bipolar II DisorderTurkey
-
The University of Texas Health Science Center at...National Institute of Mental Health (NIMH)CompletedBipolar I Disorder | Bipolar II DisorderUnited States
Clinical Trials on Interpersonal and Social Rhythm Therapy (IPSRT-BPII)
-
University of PittsburghCompletedBorderline Personality Disorder | Bipolar I DisorderUnited States
-
University of PittsburghThe Depressive and Bipolar Disorder Alternative Treatment FoundationCompletedBipolar Disorder NOSUnited States
-
University of PittsburghCompletedBipolar DisorderUnited States
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedBipolar DisorderUnited States
-
University of PittsburghCompletedBipolar Disorder | Early InterventionUnited States
-
Mayo ClinicCompletedBipolar Disorder, Depressed
-
University of PittsburghRecruiting
-
Brown UniversityThe Miriam Hospital; Michigan State University; Women and Infants Hospital of... and other collaboratorsTerminated
-
Central South UniversityCompleted
-
Emory UniversityRecruitingDepression | Alcoholism | Drug AbuseUnited States